These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34686993)

  • 1. Combining
    Girard A; Le Reste PJ; Metais A; Carsin Nicol B; Chiforeanu DC; Bannier E; Campillo-Gimenez B; Devillers A; Palard-Novello X; Le Jeune F
    J Neurooncol; 2021 Dec; 155(3):287-295. PubMed ID: 34686993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
    Pafundi DH; Laack NN; Youland RS; Parney IF; Lowe VJ; Giannini C; Kemp BJ; Grams MP; Morris JM; Hoover JM; Hu LS; Sarkaria JN; Brinkmann DH
    Neuro Oncol; 2013 Aug; 15(8):1058-67. PubMed ID: 23460322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.
    Song S; Cheng Y; Ma J; Wang L; Dong C; Wei Y; Xu G; An Y; Qi Z; Lin Q; Lu J
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1458-1467. PubMed ID: 31919633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy target volume definition in newly diagnosed high grade glioma using
    Dissaux G; Dissaux B; Kabbaj OE; Gujral DM; Pradier O; Salaün PY; Seizeur R; Bourhis D; Ben Salem D; Querellou S; Schick U
    Radiother Oncol; 2020 Sep; 150():164-171. PubMed ID: 32580001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.
    Cicone F; Filss CP; Minniti G; Rossi-Espagnet C; Papa A; Scaringi C; Galldiks N; Bozzao A; Shah NJ; Scopinaro F; Langen KJ
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):905-15. PubMed ID: 25750084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
    Youland RS; Pafundi DH; Brinkmann DH; Lowe VJ; Morris JM; Kemp BJ; Hunt CH; Giannini C; Parney IF; Laack NN
    J Neurooncol; 2018 May; 137(3):583-591. PubMed ID: 29330751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced MR imaging and
    Piccardo A; Tortora D; Mascelli S; Severino M; Piatelli G; Consales A; Pescetto M; Biassoni V; Schiavello E; Massollo M; Verrico A; Milanaccio C; Garrè ML; Rossi A; Morana G
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1685-1694. PubMed ID: 31030232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
    Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.
    Morana G; Piccardo A; Tortora D; Puntoni M; Severino M; Nozza P; Ravegnani M; Consales A; Mascelli S; Raso A; Cabria M; Verrico A; Milanaccio C; Rossi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2084-2093. PubMed ID: 28752225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of multiparametric 18F-fluoro-L-3,4-dihydroxy-phenylalanine PET/MRI in post-therapy assessment of patients with gliomas.
    Fraioli F; Shankar A; Hyare H; Ferrazzoli V; Militano V; Samandouras G; Mankad K; Solda F; Zaccagna F; Mehdi E; Lyasheva M; Bomanji J; Novruzov F
    Nucl Med Commun; 2020 Jun; 41(6):517-525. PubMed ID: 32282634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Static
    Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J
    Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial results of a phase II trial of
    Breen WG; Youland RS; Giri S; Jacobson SB; Pafundi DH; Brown PD; Hunt CH; Mahajan A; Ruff MW; Kizilbash SH; Uhm JH; Routman DM; Jones JE; Brinkmann DH; Laack NN
    J Neurooncol; 2022 Jul; 158(3):323-330. PubMed ID: 35583721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of
    Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2257-2265. PubMed ID: 28831534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas.
    Louarn N; Kauv P; Capelle L; Mokhtari K; Itti E
    Clin Nucl Med; 2021 Jul; 46(7):e353-e354. PubMed ID: 33577196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.
    Morana G; Puntoni M; Garrè ML; Massollo M; Lopci E; Naseri M; Severino M; Tortora D; Rossi A; Piccardo A
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1664-72. PubMed ID: 26911489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
    Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
    J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.
    Karunanithi S; Sharma P; Kumar A; Khangembam BC; Bandopadhyaya GP; Kumar R; Goenka A; Gupta DK; Malhotra A; Bal C
    Eur Radiol; 2013 Sep; 23(9):2628-35. PubMed ID: 23624623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of O-(2-
    Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
    World Neurosurg; 2018 May; 113():e727-e737. PubMed ID: 29510293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of anti-3-[
    Karlberg A; Pedersen LK; Vindstad BE; Skjulsvik AJ; Johansen H; Solheim O; Skogen K; Kvistad KA; Bogsrud TV; Myrmel KS; Giskeødegård GF; Ingebrigtsen T; Berntsen EM; Eikenes L
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):496-509. PubMed ID: 37776502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.